PFF Clinical Trial Finder

Best Clinical Endpoints That Likely Induce Worse Prognosis in Interstitial Lung Diseases

Study Purpose

This prospective cohort study will investigate whether progression of the interstitial lung diseases is related to specific clinical endpoints and their changes over time. Longitudinal data of patients will be compared to an age-matched control group during a follow-up of at least two years.

Recruitment Criteria

Healthy volunteers are participants who do not have a disease or condition, or related conditions or symptoms

Accepts Healthy Volunteers
Yes

An interventional clinical study is where participants are assigned to receive one or more interventions (or no intervention) so that researchers can evaluate the effects of the interventions on biomedical or health-related outcomes.


An observational clinical study is where participants identified as belonging to study groups are assessed for biomedical or health outcomes.


Searching Both is inclusive of interventional and observational studies.

Study Type
Observational
Eligible Ages 40 Years - 75 Years
Gender All
More Inclusion & Exclusion Criteria

Inclusion Criteria:

1. Patients with interstitial lung disease:
  • - Age between 40 and 75 years old upon inclusion; - Diagnosis of interstitial lung disease; - Clinical stability for at least 4 weeks prior to inclusion; - Absence of any comorbidity that interferes with the performance of tests; 2.
Age-matched control group: - Age between 40 and 75 years old upon inclusion; - Absence of any comorbidity that interferes with the performance of tests; Exclusion Criteria (both groups): - Participants that present severe or unstable cardiac disease identified during the cardiopulmonary exercise testing; - Participants with cognitive deficit that interfere with any of the tests;

Trial Details

This trial id was obtained from ClinicalTrials.gov, a service of the U.S. National Institutes of Health, providing information on publicly and privately supported clinical studies of human participants with locations in all 50 States and in 196 countries.

Trial ID:
NCT03400839

Phase 1: Studies that emphasize safety and how the drug is metabolized and excreted in humans.

Phase 2: Studies that gather preliminary data on effectiveness (whether the drug works in people who have a certain disease or condition) and additional safety data.

Phase 3: Studies that gather more information about safety and effectiveness by studying different populations and different dosages and by using the drug in combination with other drugs.

Phase 4: Studies occurring after FDA has approved a drug for marketing, efficacy, or optimal use.

Phase

The sponsor is the organization or person who oversees the clinical study and is responsible for analyzing the study data.

Lead Sponsor
Universidade Estadual de Londrina

The person who is responsible for the scientific and technical direction of the entire clinical study.

Principal Investigator
Carlos A Camillo, PT, PhD
Principal Investigator Affiliation Universidade Estadual de Londrina

Category of organization(s) involved as sponsor (and collaborator) supporting the trial.

Agency Class
OtherOther
Overall Status Recruiting
Countries Brazil

The disease, disorder, syndrome, illness, or injury that is being studied.

Conditions
Interstitial Lung Disease

Contact a Trial Team

If you are interested in learning more about this trial, find the trial site nearest to your location and contact the site coordinator via email or phone. We also strongly recommend that you consult with your healthcare provider about the trials that may interest you and refer to our terms of service below.

International Sites

Universidade Estadual de Londrina, Londrina, ParanĂ¡, Brazil

Status

Recruiting

Address

Universidade Estadual de Londrina

Londrina, ParanĂ¡, 86038-350

Site Contact

Carlos A Camillo, PT, PhD

carlos.a.camillo@outlook.com

+554333712490

Terms of Service

The PFF does not promote or represent that any investigational new drugs mentioned are safe or effective. The content provided on clinical trials is for informational purposes only and is not a substitute for medical consultation with your healthcare provider. We do not recommend or endorse any specific study and you are advised to discuss the information shown with your healthcare provider. While we believe the information presented on this website to be accurate at the time of writing, we do not guarantee that its contents are correct, complete, or applicable to any particular individual situation. We strongly encourage individuals to seek out appropriate medical advice and treatment from their physicians. We cannot guarantee the availability of any clinical trial listed and will not be responsible if you are considered ineligible to participate in a given clinical trial. We are also not liable for any injury arising as a result of participation. The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. For a full description of terms please refer to our Terms, Conditions & Privacy.

Back to Top
footer_txt_bblBook a PFF Ambassador for your event.   Call 844.TalkPFF >